Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.310
-0.060 (-2.53%)
May 14, 2025, 1:24 PM - Market open
Vistagen Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $0.2 → $15 | Hold → Strong Buy | Upgrades | $0.2 → $15 | +549.35% | Dec 7, 2023 |
| Stifel | Stifel | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +419.48% | Nov 14, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +1,198.70% | Sep 5, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +1,198.70% | Aug 7, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 26, 2022 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 22, 2022 |
| Baird | Baird | Buy Initiates $270 | Buy | Initiates | $270 | +11,588.31% | May 20, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +7,692.21% | Feb 18, 2021 |
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jan 4, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +7,692.21% | Oct 8, 2020 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 28, 2019 |
| Maxim Group | Maxim Group | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +7,692.21% | Jun 27, 2018 |